2023-03-012024-02-292024-02-29false10015064OPTICAL PHARM LTD2024-10-0147910iso4217:GBPxbrli:pure100150642023-03-01100150642024-02-29100150642023-03-012024-02-29100150642022-03-01100150642023-02-28100150642022-03-012023-02-2810015064bus:SmallEntities2023-03-012024-02-2910015064bus:AuditExempt-NoAccountantsReport2023-03-012024-02-2910015064bus:AbridgedAccounts2023-03-012024-02-2910015064bus:PrivateLimitedCompanyLtd2023-03-012024-02-2910015064core:WithinOneYear2024-02-2910015064core:AfterOneYear2024-02-2910015064core:WithinOneYear2023-02-2810015064core:AfterOneYear2023-02-2810015064core:ShareCapital2024-02-2910015064core:SharePremium2024-02-2910015064core:RevaluationReserve2024-02-2910015064core:OtherReservesSubtotal2024-02-2910015064core:RetainedEarningsAccumulatedLosses2024-02-2910015064core:ShareCapital2023-02-2810015064core:SharePremium2023-02-2810015064core:RevaluationReserve2023-02-2810015064core:OtherReservesSubtotal2023-02-2810015064core:RetainedEarningsAccumulatedLosses2023-02-2810015064core:LandBuildings2024-02-2910015064core:PlantMachinery2024-02-2910015064core:Vehicles2024-02-2910015064core:FurnitureFittings2024-02-2910015064core:OfficeEquipment2024-02-2910015064core:NetGoodwill2024-02-2910015064core:IntangibleAssetsOtherThanGoodwill2024-02-2910015064core:ListedExchangeTraded2024-02-2910015064core:UnlistedNon-exchangeTraded2024-02-2910015064core:LandBuildings2023-02-2810015064core:PlantMachinery2023-02-2810015064core:Vehicles2023-02-2810015064core:FurnitureFittings2023-02-2810015064core:OfficeEquipment2023-02-2810015064core:NetGoodwill2023-02-2810015064core:IntangibleAssetsOtherThanGoodwill2023-02-2810015064core:ListedExchangeTraded2023-02-2810015064core:UnlistedNon-exchangeTraded2023-02-2810015064core:LandBuildings2023-03-012024-02-2910015064core:PlantMachinery2023-03-012024-02-2910015064core:Vehicles2023-03-012024-02-2910015064core:FurnitureFittings2023-03-012024-02-2910015064core:OfficeEquipment2023-03-012024-02-2910015064core:NetGoodwill2023-03-012024-02-2910015064core:IntangibleAssetsOtherThanGoodwill2023-03-012024-02-2910015064core:ListedExchangeTraded2023-03-012024-02-2910015064core:UnlistedNon-exchangeTraded2023-03-012024-02-2910015064core:MoreThanFiveYears2023-03-012024-02-2910015064core:Non-currentFinancialInstruments2024-02-2910015064core:Non-currentFinancialInstruments2023-02-2810015064dpl:CostSales2023-03-012024-02-2910015064dpl:DistributionCosts2023-03-012024-02-2910015064core:LandBuildings2023-03-012024-02-2910015064core:PlantMachinery2023-03-012024-02-2910015064core:Vehicles2023-03-012024-02-2910015064core:FurnitureFittings2023-03-012024-02-2910015064core:OfficeEquipment2023-03-012024-02-2910015064dpl:AdministrativeExpenses2023-03-012024-02-2910015064core:NetGoodwill2023-03-012024-02-2910015064core:IntangibleAssetsOtherThanGoodwill2023-03-012024-02-2910015064dpl:GroupUndertakings2023-03-012024-02-2910015064dpl:ParticipatingInterests2023-03-012024-02-2910015064dpl:GroupUndertakingscore:ListedExchangeTraded2023-03-012024-02-2910015064core:ListedExchangeTraded2023-03-012024-02-2910015064dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-03-012024-02-2910015064core:UnlistedNon-exchangeTraded2023-03-012024-02-2910015064dpl:CostSales2022-03-012023-02-2810015064dpl:DistributionCosts2022-03-012023-02-2810015064core:LandBuildings2022-03-012023-02-2810015064core:PlantMachinery2022-03-012023-02-2810015064core:Vehicles2022-03-012023-02-2810015064core:FurnitureFittings2022-03-012023-02-2810015064core:OfficeEquipment2022-03-012023-02-2810015064dpl:AdministrativeExpenses2022-03-012023-02-2810015064core:NetGoodwill2022-03-012023-02-2810015064core:IntangibleAssetsOtherThanGoodwill2022-03-012023-02-2810015064dpl:GroupUndertakings2022-03-012023-02-2810015064dpl:ParticipatingInterests2022-03-012023-02-2810015064dpl:GroupUndertakingscore:ListedExchangeTraded2022-03-012023-02-2810015064core:ListedExchangeTraded2022-03-012023-02-2810015064dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-03-012023-02-2810015064core:UnlistedNon-exchangeTraded2022-03-012023-02-2810015064core:NetGoodwill2024-02-2910015064core:IntangibleAssetsOtherThanGoodwill2024-02-2910015064core:LandBuildings2024-02-2910015064core:PlantMachinery2024-02-2910015064core:Vehicles2024-02-2910015064core:FurnitureFittings2024-02-2910015064core:OfficeEquipment2024-02-2910015064core:AfterOneYear2024-02-2910015064core:WithinOneYear2024-02-2910015064core:ListedExchangeTraded2024-02-2910015064core:UnlistedNon-exchangeTraded2024-02-2910015064core:ShareCapital2024-02-2910015064core:SharePremium2024-02-2910015064core:RevaluationReserve2024-02-2910015064core:OtherReservesSubtotal2024-02-2910015064core:RetainedEarningsAccumulatedLosses2024-02-2910015064core:NetGoodwill2023-02-2810015064core:IntangibleAssetsOtherThanGoodwill2023-02-2810015064core:LandBuildings2023-02-2810015064core:PlantMachinery2023-02-2810015064core:Vehicles2023-02-2810015064core:FurnitureFittings2023-02-2810015064core:OfficeEquipment2023-02-2810015064core:AfterOneYear2023-02-2810015064core:WithinOneYear2023-02-2810015064core:ListedExchangeTraded2023-02-2810015064core:UnlistedNon-exchangeTraded2023-02-2810015064core:ShareCapital2023-02-2810015064core:SharePremium2023-02-2810015064core:RevaluationReserve2023-02-2810015064core:OtherReservesSubtotal2023-02-2810015064core:RetainedEarningsAccumulatedLosses2023-02-2810015064core:NetGoodwill2022-03-0110015064core:IntangibleAssetsOtherThanGoodwill2022-03-0110015064core:LandBuildings2022-03-0110015064core:PlantMachinery2022-03-0110015064core:Vehicles2022-03-0110015064core:FurnitureFittings2022-03-0110015064core:OfficeEquipment2022-03-0110015064core:AfterOneYear2022-03-0110015064core:WithinOneYear2022-03-0110015064core:ListedExchangeTraded2022-03-0110015064core:UnlistedNon-exchangeTraded2022-03-0110015064core:ShareCapital2022-03-0110015064core:SharePremium2022-03-0110015064core:RevaluationReserve2022-03-0110015064core:OtherReservesSubtotal2022-03-0110015064core:RetainedEarningsAccumulatedLosses2022-03-0110015064core:AfterOneYear2023-03-012024-02-2910015064core:WithinOneYear2023-03-012024-02-2910015064core:Non-currentFinancialInstrumentscore:CostValuation2023-03-012024-02-2910015064core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-012024-02-2910015064core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-012024-02-2910015064core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-012024-02-2910015064core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-012024-02-2910015064core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-012024-02-2910015064core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-012024-02-2910015064core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-012024-02-2910015064core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-012024-02-2910015064core:Non-currentFinancialInstrumentscore:CostValuation2024-02-2910015064core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-02-2910015064core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-02-2910015064core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-02-2910015064core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-02-2910015064core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-02-2910015064core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-02-2910015064core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-02-2910015064core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-02-2910015064core:Non-currentFinancialInstrumentscore:CostValuation2023-02-2810015064core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-02-2810015064core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-02-2810015064core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-02-2810015064core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-02-2810015064core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-02-2810015064core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-02-2810015064core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-02-2810015064core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-02-2810015064bus:Director12023-03-012024-02-29

OPTICAL PHARM LTD

Registered Number
10015064
(England and Wales)

Unaudited Financial Statements for the Year ended
29 February 2024

OPTICAL PHARM LTD
Company Information
for the year from 1 March 2023 to 29 February 2024

Director

Hardev Singh Bhopal

Registered Address

92c Boldmere Road
Birmingham
B73 5UB

Place of Business


Registered Number

10015064 (England and Wales)
OPTICAL PHARM LTD
Balance Sheet as at
29 February 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets31,5181,897
1,5181,897
Current assets
Stocks83,05860,698
Debtors44,1702,894
Cash at bank and on hand49,6865,002
136,91468,594
Creditors amounts falling due within one year5(122,333)(87,625)
Net current assets (liabilities)14,581(19,031)
Total assets less current liabilities16,099(17,134)
Net assets16,099(17,134)
Capital and reserves
Called up share capital100100
Profit and loss account15,999(17,234)
Shareholders' funds16,099(17,134)
The financial statements were approved and authorised for issue by the Director on 1 October 2024, and are signed on its behalf by:
Hardev Singh Bhopal
Director
Registered Company No. 10015064
OPTICAL PHARM LTD
Notes to the Financial Statements
for the year ended 29 February 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Straight line (years)
Fixtures and fittings15
Stocks and work in progress
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
2.Average number of employees

20242023
Average number of employees during the year21
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 March 235,056
At 29 February 245,056
Depreciation and impairment
At 01 March 233,159
Charge for year379
At 29 February 243,538
Net book value
At 29 February 241,518
At 28 February 231,897
4.Debtors: amounts due within one year

2024

2023

££
Other debtors4,1702,894
Total4,1702,894
5.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables13,3802,024
Taxation and social security3,664198
Other creditors105,28985,403
Total122,33387,625